Back to Authors

Zhang, L.

Mayo Clinic

Denovo Biopharma LLC (United States)

Citations 1

PHASE III RANDOMIZED STUDY OF ENZASTAURIN/R‐CHOP VS PLACEBO/R‐CHOP IN FRONTLINE HIGH RISK DIFFUSE LARGE B CELL LYMPHOMA PATIENTS WITH GENOMIC BIOMARKER DGM1 (ENGINE STUDY)
Zhu, Jun , Smith, Stephen D. , O’Connor, Owen A. , Luo, Wen‐Lin, Shazer, Ronald , Zhang, L., Han, Isabel, Jivani, Manoj A., Liu, Y. , Nowakowski, Grzegorz S. , Song, Yuqin

Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 70-70

10.1002/hon.37_2629 Get It